Global Repositioning: PayPal's Buyout Rejection and Otis's Valuation ResetGlobal Report·18 hours agoZTS+0.77%OTIS+0.57%
Insmed Chair and CEO William Lewis disposes of 10,700 common shares worth $1.14 millionPUBT·Jul 24 at 04:03 PMINSM-0.57%
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga_article·Jul 21 at 06:58 AMTRVI+1.71%ELDN-4.76%
Fifth Third Bancorp Boosts Stock Position in Insmed, Inc. $INSMMarket Beat·Jul 21 at 02:29 AMINSM-0.57%
Matt Phipps Reiterates Buy on Insmed, Citing Strong TPIP PAH Data, Solid Brinsupri/Arikayce Growth, and Overdone Share PullbackTip Ranks·Jul 16 at 12:15 PMINSM-0.57%
Insmed reports positive 12-month TPIP extension data in pulmonary arterial hypertension studyPUBT·Jul 16 at 06:03 AMINSM-0.57%
Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension | INSM Stock NewsStockTitan·Jul 15 at 10:00 PMINSM-0.57%
Insmed, Inc. (NASDAQ:INSM) Receives Average Rating of "Moderate Buy" from AnalystsMarket Beat·Jul 12 at 11:29 AMINSM-0.57%
Insmed Chair, CEO William Lewis sells 10,699 shares for $1.26 millionPUBT·Jul 10 at 03:04 PMINSM-0.57%
Insmed CMO Martina Flammer disposes of common shares worth $1.35 millionPUBT·Jul 8 at 03:04 PMINSM-0.57%
